Try a new search

Format these results:

Searched for:

in-biosketch:yes

person:kolode01

Total Results:

358


5-Fluorocytosine-mediated apoptosis and DNA damage in glioma cells engineered to express cytosine deaminase and their enhancement with interferon

Wang ZH; Samuels S; Gama Sosa MA; Kolodny EH
To explore the antitumor mechanism of bacterial cytosine deaminase plus 5-fluorocytosine (CD/5-FCyt) in combination with interferons (IFNs), glioma cells were transduced with recombinant retroviruses expressing CD. The transduced glioma cells become sensitive to the nontoxic prodrug 5-FCyt. Apoptosis, DNA damage, bystander effect, and inhibition of thymidylate synthase (TS) and DNA synthesis are associated with CD/5-FCyt-mediated glioma cell killing. Furthermore, IFNs enhance this effect by increasing DNA damage and further inhibiting TS activity. The bystander effect is mediated by the release of cytotoxic metabolites of 5-FCyt into the extracellular milieu triggering apoptosis and DNA damage. Our data indicate that the use of CD/5-FCyt in combination with IFNs may provide a more effective approach for the treatment of brain tumors
PMID: 9524100
ISSN: 0167-594x
CID: 9850

Use of amphotropic recombinant SL3-3 retroviruses in the stable reversion of the Tay-Sachs phenotype in human brain cells [Meeting Abstract]

Sosa, MAG; DeGasperi, R; Sugandhi, NS; Lehrerfeld, TJ; Undevia, S; Kolodny, EH
ISI:000071446002419
ISSN: 0002-9297
CID: 53618

An alteration in the alpha-chain propeptide is associated with beta-hexosaminidase A pseudodeficiency [Meeting Abstract]

De Gasperi, R; Sosa, MAG; Horowitz, M; Mitchell, DA; Lehrerfeld, T; Kolodny, EH
ISI:000071446001453
ISSN: 0002-9297
CID: 53607

Multiple mutations in the galactocerebrosidase gene are associated with a very mild late-onset form of globoid cell leukodystrophy [Meeting Abstract]

Kolodny, EH; Sosa, MAG; Battistini, S; Sartorato, E; Raghavan, S; DeGasperi, R
ISI:A1997XV47600220
ISSN: 0364-5134
CID: 74945

A human cell surface protein recognized by a anti-galactosylceramide monoclonal antibody [Meeting Abstract]

Sosa, MAG; DeGasperi, R; Battistini, S; Gorman, MP; Kolodny, R; Kolodny, EH
ISI:A1997XM28500016
ISSN: 0022-3042
CID: 74946

N-acetyl aspartoglutamate metabolism in brain: Application to Canavan disease [Meeting Abstract]

Leshinsky, E; Ribeiro, L; Gage, DA; Kolodny, EH
ISI:A1997XM28500755
ISSN: 0022-3042
CID: 74947

Correlation of glioma cell regression with inhibition of insulin-like growth factor 1 and insulin-like growth factor-binding protein-2 expression

Wang ZH; Ma J; Zeng BJ; Catanese VM; Samuels S; Gama Sosa MA; Kolodny EH
To explore the antitumor effect of insulin-like growth factor 1 (IGF-I) antisense RNA and the interaction of IGF-I with insulin-like growth factor-binding proteins (IGFBPs) in glioma cells, a recombinant retrovirus expressing IGF-I antisense RNA was constructed and introduced into C6 glioma cells. IGF-I antisense RNA reverses the transformed phenotype in glioma cells and inhibits glioma cell growth by blocking overexpression of endogenous IGF-I. Expression of IGFBP-2 is increased in glioma cells as compared with normal adult glial cells. IGF-I antisense RNA also inhibits expression of IGFBP-2 in glioma cells, but does not influence expression of the other IGFBPs. Although IGFBP-2 in conditioned medium from wild-type C6 cell cultures itself does not directly influence glioma cell growth, it synergistically enhances exogenous IGF-I-mediated DNA synthesis in IGF-I-negative C6 cells. These findings indicate the inhibitory effect of IGF-I antisense RNA on growth and development of glioma cells. IGF-I-dependent glioma cell growth may, in some circumstances, require IGFBP-2 as a cofactor. The antitumor effect of IGF-I antisense RNA is also associated with inhibition of IGFBP-2 expression
PMID: 9380278
ISSN: 0028-3835
CID: 9851

Krabbe's disease presenting as a peripheral neuropathy [Case Report]

Marks, H G; Scavina, M T; Kolodny, E H; Palmieri, M; Childs, J
A 13-year-old female initially presented with scoliosis and pes cavus. Initial examination revealed distal lower extremity weakness and sensory loss, as well as greater auricular nerve hypertrophy. There was a Babinski sign on the right. Nerve conduction velocities were consistent with a demyelinating neuropathy. Four years after initial presentation she developed lower extremity spasticity and bilateral Babinski signs. Magnetic resonance imaging of the brain showed diffuse white matter disease. Laboratory evaluation revealed an abnormally low galactocerebroside beta-galactosidase level. Nerve biopsy demonstrated inclusions consisting of globoid clusters and evidence of demyelination. DNA analysis was used to identify mutations consistent with Krabbe's disease. Patients presenting with an atypical peripheral neuropathy should be evaluated for Krabbe's disease
PMID: 9236794
ISSN: 0148-639x
CID: 75020

Tetrahydrobiopterin (BH4): Cofactor for dopamine beta hydroxylase (D beta H) [Meeting Abstract]

Dashman, T; Samuels, S; Leshinsky-Silver, E; Kolodny, E; Axelrod, F
ISI:000073305603137
ISSN: 0892-6638
CID: 53458

Antisulfatide IgG antibodies recognize HIV proteins [Letter]

Gama Sosa MA; De Gasperi R; Patarca R; Fletcher MA; Kolodny EH
PMID: 9215659
ISSN: 1077-9450
CID: 8408